Kenjiro Kotake
Kenjiro Kotake publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies and Gastric Cancer Management and Outcomes.
- World rank
- #2,002,787 of 7,710,434 ranked researchers
- Rank in Japan
- #36,414 of 383,136
- Works
- 206
- Citations
- 9.7k
- Citations per work
- 47.1
What does Kenjiro Kotake research?
Kenjiro Kotake's work is mostly in Medicine (81%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16780.9%
- Medicine16780.9%
- Everything else3919.1%
- 1Oncology34% of their works
- 2Surgery22% of their works
- 3Pulmonary and Respiratory Medicine13% of their works
- 4Hepatology4% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Epidemiology4% of their works
Research topics
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Intraperitoneal and Appendiceal Malignancies
- Colorectal and Anal Carcinomas
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Screening and Detection
- Genetic factors in colorectal cancer
Which keywords describe Kenjiro Kotake's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Adjuvant Chemotherapy, Gastric Cancer, Survival Analysis, Preoperative Chemoradiotherapy, Rectal Cancer and Molecular Characterization.
- Microsatellite Instability
- Colonoscopy
- Hepatocellular Carcinoma
- Anal Cancer
- Cytoreductive Surgery
- Endoscopic Resection
- KRAS Mutations
- Molecular Characterization
- Preoperative Chemoradiotherapy
- Gastric Cancer
- Clinical Practice Guidelines
- Chemotherapy
- Adjuvant Chemotherapy
- Survival Analysis
- Rectal Cancer
- Cetuximab
- Colorectal Cancer
- Lymph Node Dissection
- Intraperitoneal Chemotherapy
- Chemoradiation
- Liver Cancer
- Hereditary Syndromes
- Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Chemotherapy1393 topics
- Clinical Practice Guidelines1363 topics
- Adjuvant Chemotherapy932 topics
- Gastric Cancer772 topics
- Survival Analysis772 topics
- Preoperative Chemoradiotherapy711 topic
- Rectal Cancer711 topic
- Molecular Characterization642 topics
- Cetuximab631 topic
- KRAS Mutations631 topic
- Colorectal Cancer572 topics
- Endoscopic Resection421 topic
- Lymph Node Dissection421 topic
- Cytoreductive Surgery351 topic
- Intraperitoneal Chemotherapy351 topic
- Anal Cancer341 topic
- Chemoradiation341 topic
- Hepatocellular Carcinoma231 topic
- Liver Cancer231 topic
- Colonoscopy221 topic
- Hereditary Syndromes221 topic
- Microsatellite Instability221 topic
- Screening221 topic
Where does Kenjiro Kotake work?
Kenjiro Kotake's main affiliation in the publication record is Tochigi Cancer Center, Japan.
How many publications and citations does Kenjiro Kotake have?
OpenAlex counts 206 works and 9,712 citations for Kenjiro Kotake, an h-index of 34, ranking #2,002,787 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kenjiro Kotake. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.